IQARUS INTERNATIONAL LIMITED

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +11.5%

  £17,835,586 → £19,891,233

• Cash

  +29.7%

  £302,531 → £392,436

• Net assets

  -236.8%

  -£1,454,554 → -£4,899,040

• Employees

  +66.7%

  15 → 25

• Operating profit

  -75.7%

  -£360,811 → -£633,945

• Profit before tax

  -1,020.3%

  -£428,353 → -£4,798,828

• Wages

  +84.9%

  £1,047,096 → £1,935,840

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. IQARUS INTERNATIONAL LIMITED 2016-10-03 → present
2. IQARUS TRAINING LIMITED 2016-04-18 → 2016-10-03
3. EX-MED UK LIMITED 2004-03-22 → 2016-04-18

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Azets Audit Services

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors believe that preparing the financial statements on a going concern basis is appropriate due to a number of factors. The business meets its day to day working capital needs through internal cash management within intercompany and banking facilities. The Board have sensitised forecasts and projections for the next 12 months to take into account possible downside scenarios in trading circumstances to determine when and to what extent additional measures may be necessary. The Board are confident of their ability to meet all obligations for a period of at least 12 months from the date of approval of these financial statements.”

Group structure

1. IQARUS INTERNATIONAL LIMITED · parent
   1. Iqarus Pte Ltd 100% · Singapore
   2. LLC Iqarus Medical Solutions 100% · Ukraine

Significant events

• “On 18 November 2025, the Company issued 6,000,000 ordinary shares of £1 each to its parent company in settlement of £6,000,000 ($7,905,138) of amounts owed to group undertakings. This transaction occurred after the reporting date and is therefore treated as a non-adjusting subsequent event.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

1

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.